These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 645175)

  • 1. Immunological studies of hsv-infection of resistant and susceptible inbred strains of mice.
    Kirschner H; Kochen M; Hirt HM; Munk K
    Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):147-54. PubMed ID: 645175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar immune response to nonlethal infection with herpes simplex virus-1 in sensitive (BALB/c) and resistant (C57BL/6) strains of mice.
    Brenner GJ; Cohen N; Moynihan JA
    Cell Immunol; 1994 Sep; 157(2):510-24. PubMed ID: 8069930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system in mice.
    Kastrukoff LF; Lau AS; Puterman ML
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():613-21. PubMed ID: 3007658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSV-1 infection and immunity in immunosuppressed mice.
    Litwińska B; Sadowski W; Kańtoch M
    Acta Virol; 1987 Aug; 31(4):298-306. PubMed ID: 2892379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR; Yang L; Voytek C; Margolis TP
    Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression of mice by cyclophosphamide (CyP) and cyclosporin A (CsA) changes the course of HSV-1 infection and the distribution of viral DNA in target organs.
    Berkowitz-Balshayi C; Rösen-Wolff A; Darai G; Becker Y
    In Vivo; 1995; 9(2):155-62. PubMed ID: 7548792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic resistance to viral infection. Mouse macrophage restriction of herpes simplex virus replication.
    Sarmiento M
    J Immunol; 1988 Oct; 141(8):2740-8. PubMed ID: 2844905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunogenetic analysis of resistance to herpes simplex virus retinitis in inbred strains of mice.
    Pepose JS; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1549-52. PubMed ID: 3040616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spread of HSV and establishment of latency after corneal infection in inbred mice.
    Abghari SZ; Stulting RD; Nigida SM; Downer DN; Nahmias AJ
    Invest Ophthalmol Vis Sci; 1986 Jan; 27(1):77-82. PubMed ID: 3000975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent.
    Lundberg P; Openshaw H; Wang M; Yang HJ; Cantin E
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4162-70. PubMed ID: 17724202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of NK cells in protection of mice against herpes simplex virus-1 infection.
    Rager-Zisman B; Quan PC; Rosner M; Moller JR; Bloom BR
    J Immunol; 1987 Feb; 138(3):884-8. PubMed ID: 3805719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An adoptive cell transfer system for the evaluation of immunity to Herpes simplex virus in mice.
    Favila L; Howes EL; Taylor WA; Mitchison NA
    Clin Exp Immunol; 1982 May; 48(2):307-14. PubMed ID: 7105488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
    Cui FD; Asada H; Kishida T; Itokawa Y; Nakaya T; Ueda Y; Yamagishi H; Gojo S; Kita M; Imanishi J; Mazda O
    Gene Ther; 2003 Dec; 10(25):2059-66. PubMed ID: 14595378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vivo modulation of macrophage functions by herpes simplex virus type 2 in resistant and sensitive inbred mouse strains.
    Armerding D; Mayer P; Scriba M; Hren A; Rossiter H
    Immunobiology; 1981; 160(2):217-27. PubMed ID: 7319542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    Mitchell BM; Stevens JG
    J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous antibody is protective against HSV-1 infection of the immunocompromised mouse.
    Alexander TS; Rosenthal KS
    J Lab Clin Med; 1990 Sep; 116(3):400-7. PubMed ID: 2169516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
    Tamesis RR; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
    Tengvall S; Harandi AM
    J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of mice by an apathogenic strain HSV-1 against lethal infection by a pathogenic strain of HSV-1.
    Schröeder CH; Engler H; Kirchner H
    J Gen Virol; 1981 Jan; 52(Pt 1):159-61. PubMed ID: 6267173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.